Emeritus Faculty, Acad Council, Chemical and Systems Biology
We are analyzing the mechanism by which the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) induces gene transcription. TCDD binds to an intracellular protein (the Ah receptor) which then dimerizes with a second bHLH/PAS protein (Arnt) to form a heterodimeric, DNA binding transcription factor. The AhR/Arnt complex interacts with a dioxin-responsive transcriptional enhancer located upstream of the target CYP1A1 gene. The receptor-enhancer interaction disrupts the nucleosomal structure of the regulatory region, increasing the access of the transcription factors to the CYP1A1 promoter in vivo.
Our current studies utilize techniques ranging from cell culture to molecular genetics and focus on:
(i) Identifying the protein-DNA interactions at enhancer and promoter elements for dioxin-responsive genes and understanding their contributions to the activation of gene transcription, with particular focus on enhancer-promoter communication.
(ii) Characterizing the structural and functional domains of the Ah receptor and other regulatory proteins involved in the transcriptional response to dioxin, with particular focus on the mechanism of transactivation and changes in chromatin structure.
(iii) Analyzing the mechanism by which low oxygen tension (hypoxia) induces mammalian gene transcription via bHLH/PAS proteins.
Latest information on COVID-19
Stanford Medicine is closely monitoring the outbreak of novel coronavirus (COVID-19). A new page is dedicated to the latest information and developments about COVID-19.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
The 368-bed hospital building, which celebrates its one-year anniversary on Nov. 17, features technology and design features that have made handling COVID-19 cases easier.